2024-06-30 05:20:25 ET
Summary
- LeMaitre is a long-term compounder with mouth-watering economics and shareholder-friendly management.
- LMAT shares have rallied 45% since August '23, with increased dividends and improving fundamentals.
- Management has lengthened the reinvestment runway to deploy funds into the business at an advantage to drive further growth in corporate value.
- Valuation upsides are supported by growth catalysts outlined here.
Investment Summary
Following my last report on LeMaitre Vascular, Inc. ( LMAT ) in August FY’23, shares have rallied another 45% into the green, along with 1) increased dividends and 2) improving fundamentals. Back then, I valued the stock at ~$85/share, roughly where it trades today....
Read the full article on Seeking Alpha
For further details see:
LeMaitre: Further Upsides Supported By Longer Competitive Advantage Period